Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Open in API
Filings indexed 428 across all filing types
Latest filing 2026-02-09 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notification to the stock exchange about an upcoming Board Meeting to approve the Un-Audited Financial Results for the third quarter and nine months ended December 31, 2025. It is an intimation of the meeting date and agenda, not the actual financial results or report. The document is short (1552 characters) and serves as a meeting notice rather than a report or detailed financial disclosure. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not contain the financial data itself.
2026-02-09 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Ltd. regarding a clarification on the non-submission of comparative figures for consolidated financial results for a specific quarter and half year period. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements, and explains the reason for the absence of comparative consolidated figures due to a recent acquisition and change in accounting treatment. The document does not contain actual financial statements or detailed financial data, but rather a compliance clarification letter. It is short (2411 characters) and serves as a regulatory communication rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and clarification.
2026-02-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018, covering the quarter ended 31st December 2025. It certifies details about securities dematerialized/rematerialized during the quarter and confirms that the regulation is not applicable as all shares are in demat form. The document is a compliance certificate rather than a financial report or announcement of financial results. It is primarily an officer certification letter submitted to the stock exchange. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS). The document length is short (2479 characters), and it does not contain financial statements or substantive financial data. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-01-14 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to the National Stock Exchange of India regarding the closure of the trading window. It references the upcoming release of the company's un-audited financial results for the fourth quarter ending December 31, 2025, and instructs officers and designated employees not to trade during this period. The document does not contain any financial data or results itself, nor does it announce or present a report. Instead, it is an announcement related to compliance and trading restrictions ahead of a financial disclosure. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory compliance announcement that does not fit into other specific categories like earnings release or interim report.
2025-12-27 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to the National Stock Exchange of India regarding the listing and trading approval of equity shares issued on a preferential basis following the conversion of warrants. It includes details about the number of shares, distinctive numbers, lock-in periods, and confirmation of listing and admission to dealings on the exchange. The document is a formal announcement of a capital market event related to share issuance and listing, not a financial report or earnings release. It does not contain financial statements or management discussion but rather informs about a capital structure change and listing approval. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is about 4762 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is CAP with high confidence.
2025-12-09 English
Copy of Newspaper Publication
Regulatory Filings
2025-11-17 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.